Arcosa, Inc. (ACA) Revenue History
Annual and quarterly revenue from 2016 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ACA Revenue Growth
Revenue Breakdown (FY 2025)
ACA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
ACA Revenue Analysis (2016–2025)
As of May 16, 2026, Arcosa, Inc. (ACA) generated trailing twelve-month (TTM) revenue of $2.82 billion, reflecting moderate decline in growth of -9.5% year-over-year. The most recent quarter (Q1 2026) recorded $571.7 million in revenue, down 20.2% sequentially.
Looking at the longer-term picture, ACA's 5-year compound annual growth rate (CAGR) stands at +8.3%, indicating steady revenue expansion. The company achieved its highest annual revenue of $2.88 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows ACA's business is primarily driven by Construction Products (45%), Engineered Structures (41%), and Transportation Products (13%).
When compared to Industrials sector peers including MLM (-1.3% YoY), VMC (+7.3% YoY), and CRH (+50.3% YoY), ACA has underperformed the peer group in terms of revenue growth. Compare ACA vs MLM →
ACA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $2.8B | -9.5% | +8.3% | 11.8% | ||
| $6.5B | -1.3% | +6.7% | 23.3% | ||
| $7.9B | +7.3% | +10.3% | 20.1% | ||
| $37.4B | +50.3% | +10.7% | 14.2% | ||
| $2.2B | -27.7% | +4.3% | 16.6% | ||
| $41M | +114.0% | -1.1% | -41.2% |
ACA Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.88B | +12.2% | $647.2M | 22.4% | $340.1M | 11.8% |
| 2024 | $2.57B | +11.4% | $515.2M | 20.0% | $197.6M | 7.7% |
| 2023 | $2.31B | +2.9% | $443.8M | 19.2% | $182.7M | 7.9% |
| 2022 | $2.24B | +10.1% | $411.1M | 18.3% | $349.0M | 15.6% |
| 2021 | $2.04B | +5.2% | $355.9M | 17.5% | $107.3M | 5.3% |
| 2020 | $1.94B | +11.4% | $382.0M | 19.7% | $151.8M | 7.8% |
| 2019 | $1.74B | +18.9% | $332.4M | 19.1% | $152.9M | 8.8% |
| 2018 | $1.46B | -0.1% | $272.0M | 18.6% | $94.9M | 6.5% |
| 2017 | $1.46B | -14.2% | $294.7M | 20.2% | $131.7M | 9.0% |
| 2016 | $1.70B | - | $348.1M | 20.4% | $200.8M | 11.8% |
See ACA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACA vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonACA — Frequently Asked Questions
Quick answers to the most common questions about buying ACA stock.
Is ACA's revenue growth accelerating or slowing?
ACA revenue declined -9.5% year-over-year, contrasting with the 5-year CAGR of +8.3%. TTM revenue fell to $2.8B. This reverses the prior growth trend.
What is ACA's long-term revenue growth rate?
Arcosa, Inc.'s 5-year revenue CAGR of +8.3% reflects the variable expansion pattern. Current YoY growth of -9.5% is below this long-term average.
How is ACA's revenue distributed by segment?
ACA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2025 are available for download. Segment mix reveals concentration and diversification trends.